Ranibizumab and Voltaren-XR
Determining the interaction of Ranibizumab and Voltaren-XR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
Generic Name: diclofenac
Brand name: Cambia, Cataflam, Voltaren-XR, Zipsor, Zorvolex, Voltaren, Dyloject, also Cambia
Synonyms: Voltaren XR
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab-Von Willebrand Factor
- Ranibizumab-Von Willebrand factor recombinant
- Ranibizumab-Von willebrand factor recombinant Intravenous
- Ranibizumab-Vonvendi
- Ranibizumab-Vopac
- Ranibizumab-Vopac MDS
- Voltaren-XR-Ranibizumab Intraocular
- Voltaren-XR-Ranibizumab ophthalmic
- Voltaren-XR-Ranitidine
- Voltaren-XR-Ranitidine Capsule
- Voltaren-XR-Ranitidine Hydrochloride
- Voltaren-XR-Ranitidine Injection